H1-antihistamines for the treatment of anaphylaxis with and without shock
Country of origin: USA
Click for Full Details: www.mrw.interscience.wiley.comAnaphylaxis is a rare, but potentially life-threatening emergency. Evidence suggests that incidence may be increasing rapidly. Common triggers of anaphylaxis include a variety of foods, drugs and insect venoms.
H1-antihistamines are commonly used for the emergency treatment of anaphylaxis although the evidence underpinning this treatment is unclear. A systematic review of the literature has been conducted, searching key databases for high quality published and unpublished material on this subject; in addition, experts in this area and relevant pharmaceutical companies were contacted.
The searches failed to retrieve any randomised controlled trials on this subject. The review concludes there is no evidence from randomised controlled trials to support the use of H1-antihistamines in the emergency management of anaphylaxis.
The Cochrane review is available online.
Click for Full Details: www.mrw.interscience.wiley.com
Clinical Pain Advisor June 2018
NHS Information Centre Indicator Portal June 2018
Managing Head Injury June 2018
The science behind drug abuse June 2018
Learning From Serious Failings In Care June 2018
Trauma Nursing May 2018
Anticoagulation Manager May 2018
Revised Pandemic Influenza Strategy May 2018
VR Robotic Urology May 2018